Yutaka Shimazu Masaharu Nohgawa
10.3960/jslrt.19004
J Clin Exp Hematop
2019;59(2):93-95.
diffuse large b-cell lymphoma liver failure rituximab
CC BY-NC-SA
https://pubmed.ncbi.nlm.nih.gov/31257349/
Antineoplastic Combined Chemotherapy Protocols / adverse effects Liver Failure / diagnosis Liver Failure / etiology Lymphoma, Large B-Cell, Diffuse / complications Lymphoma, Large B-Cell, Diffuse / drug therapy
Antineoplastic Combined Chemotherapy Protocols / adverse effects Liver Failure / diagnosis Liver Failure / etiology Lymphoma, Large B-Cell, Diffuse / complications Lymphoma, Large B-Cell, Diffuse / drug therapy Case Reports Letter Aged Antineoplastic Agents, Immunological / administration & dosage Antineoplastic Combined Chemotherapy Protocols / therapeutic use Biomarkers Biomarkers, Tumor Biopsy Cyclophosphamide / adverse effects Cyclophosphamide / therapeutic use Doxorubicin / adverse effects Doxorubicin / therapeutic use Humans Liver Failure / therapy Lymphoma, Large B-Cell, Diffuse / diagnosis Male Molecular Targeted Therapy Positron-Emission Tomography Prednisone / adverse effects Prednisone / therapeutic use Rituximab / administration & dosage Rituximab / adverse effects Rituximab / therapeutic use Tomography, X-Ray Computed Vincristine / adverse effects Vincristine / therapeutic use Antineoplastic Agents, Immunological Biomarkers Biomarkers, Tumor R-CHOP protocol Rituximab Vincristine Doxorubicin Cyclophosphamide Prednisone
PMC6661963
31257349
DLBCL developed into fatal liver failure during rituximab-containing chemotherapy
2019